Invest now
Aarti Drugs Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -418.15 -4.80 (-1.13%)Updated : 20 Jul 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 2,815.26 | 2,574.68 | 2,432.36 | 2,421.40 |
| Cash Equivalents | 8.81 | 4.58 | 6.74 | 7.50 |
| Other Liabilities Total | 4.77 | 4.49 | 2.91 | 3.20 |
| Long Term Debt | 256.87 | 284.00 | 275.33 | 204.68 |
| Common Stock Total | 91.27 | 91.27 | 91.94 | 92.60 |
| Other Equity Total | 0.01 | 10.50 | 8.91 | 8.85 |
| Other Current Assets Total | 122.14 | 81.45 | 109.77 | 89.93 |
| Total Assets | 2,815.26 | 2,574.68 | 2,432.36 | 2,421.40 |
| Current Portof LT Debt/ Capital Leases | 318.91 | 57.59 | 73.33 | 403.83 |
| Total Equity | 1,548.87 | 1,369.00 | 1,281.55 | 1,192.43 |
| Long Term Investments | 27.31 | 22.41 | 19.97 | 18.80 |
| Retained Earnings( Accumulated Deficit) | 1,457.59 | 1,267.23 | 1,180.71 | 1,090.99 |
| Total Common Shares Outstanding | 9.13 | 9.13 | 9.19 | 9.26 |
| Tangible Book Valueper Share Common Eq | 167.90 | 143.07 | 135.39 | 126.14 |
| Total Liabilities | 1,266.39 | 1,205.68 | 1,150.81 | 1,228.96 |
| Total Debt | 576.64 | 615.07 | 564.28 | 608.91 |
| Short Term Investments | 15.47 | 17.00 | 13.07 | 12.21 |
| Cashand Short Term Investments | 24.28 | 21.57 | 19.82 | 19.71 |
| Total Receivables Net | 830.57 | 762.41 | 705.24 | 865.85 |
| Deferred Income Tax | 81.27 | 78.23 | 75.71 | 70.97 |
| Accounts Receivable- Trade Net | 829.87 | 751.18 | 704.55 | 864.84 |
| Property/ Plant/ Equipment Total- Net | 1,283.78 | 1,133.10 | 1,035.14 | 862.24 |
| Minority Interest | 0.36 | 0.34 | 0.41 | 0.23 |
| Total Current Liabilities | 922.26 | 836.97 | 795.54 | 949.48 |
| Total Inventory | 490.78 | 472.93 | 485.89 | 516.29 |
| Accounts Payable | 477.88 | 416.14 | 425.49 | 480.27 |
| Other Currentliabilities Total | 125.47 | 87.12 | 79.06 | 61.01 |
| Total Long Term Debt | 257.73 | 285.65 | 276.24 | 205.08 |
| Intangibles Net | 16.43 | 63.19 | 36.82 | 24.33 |
| Other Long Term Assets Total | 19.97 | 0.82 | 0.00 | 0.00 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,467.77 | 1,338.36 | 1,320.72 | 1,491.79 |
| Capital Lease Obligations | 0.86 | 1.65 | 0.91 | 0.40 |
| Accumulated Depreciation Total | - | -628.00 | -576.67 | -528.54 |
| Accrued Expenses | - | 4.29 | 2.95 | 4.37 |
| Property/ Plant/ Equipment Total- Gross | - | 1,486.96 | 1,386.58 | 1,203.98 |
| Notes Payable/ Short Term Debt | - | 271.84 | 214.70 | 0.00 |
| Note Receivable- Long Term | - | 16.80 | 19.70 | 24.23 |
*All figures in crores except per share values
Aarti Drugs Quick Links
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Profit Loss Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,570.50+59.15(3.91%)
389.85+12.70(3.37%)
2,268.25+66.45(3.02%)
1,933.10-16.90 (-0.87%)
2,840.00-19.55 (-0.68%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.